Telaprevir experience from Turkey.

Suheyla Komur1, Behice Kurtaran1, Ayse Seza Inal1

  • 1Department of Infectious Diseases, Cukurova University, Adana, Turkey.

Hepatitis Monthly
|March 20, 2015
PubMed
Summary

Telaprevir triple therapy in chronic hepatitis C patients showed promising results, with 82.1% achieving sustained virologic response, despite frequent adverse effects. This treatment is beneficial for those with prior treatment experience.

Related Concept Videos